| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2013-06-18 17:42:33 UTC |
|---|
| Update Date | 2023-02-21 17:30:07 UTC |
|---|
| HMDB ID | HMDB0060656 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Monoethylglycinexylidide |
|---|
| Description | Monoethylglycinexylidide, also known as norlidocaine or MEGX, belongs to the class of organic compounds known as alpha-amino acid amides. These are amide derivatives of alpha-amino acids. Monoethylglycinexylidide is a very strong basic compound (based on its pKa). Monoethylglycinexylidide is a metabolite of lidocaine, also known as lignocaine. Lidocaine (trade name: Xylocaine) is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, is injected as a dental anesthetic, or is injected as a local anesthetic for minor surgery (Wikipedia). Monoethylglycinexylidide and formaldehyde can be biosynthesized from lidocaine via the enzymes cytochrome P450 1A2 and cytochrome P450 3A4. |
|---|
| Structure | CCNCC(=O)NC1=C(C)C=CC=C1C InChI=1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Ethylamino-2',6'-acetoxylidide | ChEBI | | 2-Ethylamino-2,6-acetoxylidine | ChEBI | | Ethylglycylxylidide | ChEBI | | Lidocaine N-de-ethylated metabolite | ChEBI | | N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide | ChEBI | | N-Ethylglycinexylidide | ChEBI | | Norlidocaine | ChEBI | | Omega-(ethylamino)-2',6'-dimethylacetanilide | ChEBI | | MEGX | HMDB | | Monoethylglycinexylidide, 3H,1-(14)C-labeled | HMDB | | Monoethylglycinexylidide monohydrochloride | HMDB | | 2-(Ethylamino)-2',6'-acetoxylidide | HMDB | | 2-(Ethylamino)-2’,6’-acetoxylidide | HMDB | | Monoethylglycinexylidide | HMDB | | Monoethylglycylxylidide | HMDB | | N-(N-Ethylglycyl)-2,6-xylidine | HMDB | | omega-Ethylamino-2',6'-dimethylacetanilide | HMDB | | ω-Ethylamino-2',6'-dimethylacetanilide | HMDB | | ω-Ethylamino-2’,6’-dimethylacetanilide | HMDB |
|
|---|
| Chemical Formula | C12H18N2O |
|---|
| Average Molecular Weight | 206.2841 |
|---|
| Monoisotopic Molecular Weight | 206.141913208 |
|---|
| IUPAC Name | N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide |
|---|
| Traditional Name | monoethylglycinexylidide |
|---|
| CAS Registry Number | 7728-40-7 |
|---|
| SMILES | CCNCC(=O)NC1=C(C)C=CC=C1C |
|---|
| InChI Identifier | InChI=1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15) |
|---|
| InChI Key | WRMRXPASUROZGT-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Alpha amino acid amides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-amino acid amide
- Anilide
- N-arylamide
- M-xylene
- Xylene
- Monocyclic benzene moiety
- Benzenoid
- Carboxamide group
- Secondary carboxylic acid amide
- Secondary amine
- Secondary aliphatic amine
- Organopnictogen compound
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.99 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.7163 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.66 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 989.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 232.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 122.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 47.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 351.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 249.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 714.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 290.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 792.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 203.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 244.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 334.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 330.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 120.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Monoethylglycinexylidide,1TMS,isomer #1 | CCN(CC(=O)NC1=C(C)C=CC=C1C)[Si](C)(C)C | 1936.9 | Semi standard non polar | 33892256 | | Monoethylglycinexylidide,1TMS,isomer #1 | CCN(CC(=O)NC1=C(C)C=CC=C1C)[Si](C)(C)C | 1872.7 | Standard non polar | 33892256 | | Monoethylglycinexylidide,1TMS,isomer #1 | CCN(CC(=O)NC1=C(C)C=CC=C1C)[Si](C)(C)C | 2466.2 | Standard polar | 33892256 | | Monoethylglycinexylidide,1TMS,isomer #2 | CCNCC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 1702.4 | Semi standard non polar | 33892256 | | Monoethylglycinexylidide,1TMS,isomer #2 | CCNCC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 1781.9 | Standard non polar | 33892256 | | Monoethylglycinexylidide,1TMS,isomer #2 | CCNCC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2157.5 | Standard polar | 33892256 | | Monoethylglycinexylidide,2TMS,isomer #1 | CCN(CC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C)[Si](C)(C)C | 1797.1 | Semi standard non polar | 33892256 | | Monoethylglycinexylidide,2TMS,isomer #1 | CCN(CC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C)[Si](C)(C)C | 1921.8 | Standard non polar | 33892256 | | Monoethylglycinexylidide,2TMS,isomer #1 | CCN(CC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C)[Si](C)(C)C | 2134.6 | Standard polar | 33892256 | | Monoethylglycinexylidide,1TBDMS,isomer #1 | CCN(CC(=O)NC1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2150.4 | Semi standard non polar | 33892256 | | Monoethylglycinexylidide,1TBDMS,isomer #1 | CCN(CC(=O)NC1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2078.4 | Standard non polar | 33892256 | | Monoethylglycinexylidide,1TBDMS,isomer #1 | CCN(CC(=O)NC1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2559.2 | Standard polar | 33892256 | | Monoethylglycinexylidide,1TBDMS,isomer #2 | CCNCC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 1923.2 | Semi standard non polar | 33892256 | | Monoethylglycinexylidide,1TBDMS,isomer #2 | CCNCC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 1994.0 | Standard non polar | 33892256 | | Monoethylglycinexylidide,1TBDMS,isomer #2 | CCNCC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2292.7 | Standard polar | 33892256 | | Monoethylglycinexylidide,2TBDMS,isomer #1 | CCN(CC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2325.8 | Semi standard non polar | 33892256 | | Monoethylglycinexylidide,2TBDMS,isomer #1 | CCN(CC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2322.8 | Standard non polar | 33892256 | | Monoethylglycinexylidide,2TBDMS,isomer #1 | CCN(CC(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2389.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Monoethylglycinexylidide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ab9-9700000000-59871f7e43874a6af753 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Monoethylglycinexylidide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Monoethylglycinexylidide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 15V, Positive-QTOF | splash10-0a4i-9030000000-1e8c79f631ca8ed33633 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 30V, Positive-QTOF | splash10-0a4i-9010000000-29c66d7f62e059d77b2c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 45V, Positive-QTOF | splash10-0a4i-9000000000-6c644067087991a7ecb1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 120V, Positive-QTOF | splash10-0a4i-9100000000-e56658554049cc07779c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 90V, Positive-QTOF | splash10-0a4i-9000000000-99b05b954ee15f4eefb0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 30V, Positive-QTOF | splash10-0fk9-0900000000-ae83455c6a9a99b200ce | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 75V, Positive-QTOF | splash10-0a4i-9000000000-cf90d6186b3be90f2402 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 20V, Positive-QTOF | splash10-0a4i-9000000000-218972f5c57a26404e71 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 40V, Positive-QTOF | splash10-0a4i-9000000000-893dde12a40737b94603 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 10V, Positive-QTOF | splash10-0a4i-9010000000-638af66bdbd0035ebd75 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 50V, Positive-QTOF | splash10-014i-0900000000-eda489b5d46d0c474802 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 40V, Positive-QTOF | splash10-00di-0900000000-f8983882a261ea7ea6a8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 10V, Positive-QTOF | splash10-0a4i-0090000000-47b1e77b7eac9395636e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 30V, Positive-QTOF | splash10-0fk9-0900000000-cbf2c13b2a6f321172bb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 20V, Positive-QTOF | splash10-0kmi-0930000000-96aab8eb554bbefb5784 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Monoethylglycinexylidide 40V, Positive-QTOF | splash10-00di-0900000000-b6ca77499d9c16e44522 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 10V, Positive-QTOF | splash10-0a4i-9030000000-b30eeaf4741641f18682 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 20V, Positive-QTOF | splash10-0a4i-9100000000-7bcf920a7c1f71061bd3 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 40V, Positive-QTOF | splash10-0a6r-9000000000-67742f48ee8088bdd523 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 10V, Negative-QTOF | splash10-0a4i-0290000000-01db66bd1dc1702ff20a | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 20V, Negative-QTOF | splash10-0ab9-5980000000-47d25e48c36e75d3740c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 40V, Negative-QTOF | splash10-00dl-4900000000-26847048db306bbbfda5 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 10V, Positive-QTOF | splash10-0a4i-9050000000-c8d0835038a41fabcccc | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 20V, Positive-QTOF | splash10-0a4i-9000000000-1da382a29feac0562002 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Monoethylglycinexylidide 40V, Positive-QTOF | splash10-0a4l-9000000000-fd74ebb510c03728eb09 | 2021-10-12 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
|---|
| General References | - Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|